Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chonic HCV infection?
- 1 September 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (3), 362-368
- https://doi.org/10.1016/s0168-8278(98)80052-4
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The Treatment of Chronic Viral HepatitisNew England Journal of Medicine, 1997
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapyDigestive Diseases and Sciences, 1995
- Prediction of response to interferon treatment of chronic hepatitis CJournal of Hepatology, 1994
- Factors predictive of response to interferon-α therapy in hepatitis C virus infectionHepatology, 1994
- Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitisGastroenterology, 1994
- Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2bHepatology, 1993
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitisGastroenterology, 1991
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from FranceHepatology, 1991